drugset / Trial / NCT01839214
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study will examine the safety and efficacy in subjects with mild to moderate ulcerative colitis, as measured by Modified Mayo Score, Modified Baron Score, IBDQ, calprotectin and other assessments.
Timeline
- Start
- 2013-01
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VB-201 | Small molecule | 80 mg | Oral |